GTI Archives - Green Market Report

Debra BorchardtOctober 5, 2021
shutterstock_511330249-1.jpg?fit=1200%2C1667&ssl=1

4min10420

New York’s Cannabis Control Board is moving quickly to make up for the lost time under the previous administration. In the group’s first meeting since incoming Gov. Hochul stepped in and nominated people for the board, they approved raw cannabis flower as a medical product effective immediately.

Boris Jordan, the founder and chairman of Curaleaf (OTC: CURLF) said on Twitter:

Thank you, NY Gov. Hochul & the Office of Cannabis Management for allowing the sale of whole flower. This decision impacts 151k+ medical patients in NY who will now have access to quality & safe whole flower. Action (not talk) from our new Gov!

In addition to approving flower, the Board also loosened other restrictions.

  • Doctors can approve medical patients
  • 30 day supply increases to 60 day supply
  • $50 registration fee for patients is waived
  • Streamlining dispensation

Currently, New York cannabis law states that adults 21 and older can possess up to three ounces of cannabis or 24 grams of concentrates in New York. The irony is that regular citizens could legally smoke cannabis flower in public, while medical patients weren’t allowed such a form factor.

The meeting was a quick one and lasted roughly 30 minutes. The board members are Tremaine Wright (Cannabis Control Board Chair) , Jessica Garcia, Rueben McDaniel III, Jen Metzger, Adam Perry and Chris Alexander (Executive Director). The meeting also named Jason Starr as the Chief Equity Officer. He served as assistant counsel to former New York Gov. Andrew Cuomo (D) and also worked at the New York Civil Liberties Union.

Patrik Jonsson, Regional President of the Northeast at Curaleaf said, “The expansion of New York’s medical program allowing the sale of whole flower is a very big deal for the thousands of patients affected who now have access to the most cost effective and natural form of the plant. On behalf of Curaleaf and our patient community, I want to thank legislators and the Office of Cannabis Management for their leadership on this issue. This continued evolution of the medical program, which includes expanded qualifying conditions and the removal of application fees, will empower more patients to make choices that work best for their needs. These changes will give New Yorkers access to whole flower that has undergone standardized procedures and testing protocols, ensuring quality and safety. Curaleaf looks forward to expanding our product offerings to best serve our valued patients.” Curaleaf said it could have products on the shelf in November after state testing.

Stocks See Lift

Several of the cannabis companies with large exposure to New York saw stock prices immediately jump on the news. Curaleaf Stock rose as did Green Thumb Industries (GTBIF).


Video StaffSeptember 14, 2021

3min12940

Green Thumb Industries (OTC: GTBIF) is breaking ground on a cultivation center in Warwick NY, a town 54 miles north of New York City. The location is unique because the site used to be a prison that at one time held people incarcerated for cannabis. GTI’s CEO Ben Kovler told the Green Market Report that he appreciates the history of the site and notes the location is key for distribution to New York consumers. He is also pleased that the town has shown its appreciation for GTI’s investment into the facility and the jobs that it will bring.

Here are some fast facts:

The former Warwick medium-security prison, which housed about 1,000 inmates, many for drug offenses, closed just a decade ago.

  • There’s a great full-circle story here – building the modern cannabis campus on the site of a prison that was previously used to incarcerate cannabis users.
  • The $150 million investment made by Green Thumb to refurbish and remodel the site will create hundreds of construction jobs and permanent employment in the region.
  • Senator John Martucci and Assemblymember Karl Brabenec were in attendance at the groundbreaking ceremony
  • The area has a rich history. Before being a prison, the site was also home to the Warwick State Training School for Boys, which was founded in the 1920s. Eleanor Roosevelt and then-Senator Franklin Roosevelt were supporters of the school.

StaffSeptember 1, 2021
Greenstar-scaled.jpg?fit=1200%2C1200&ssl=1

3min22670

Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF) has bought Massachusetts-based GreenStar Herbals, Inc. The value of the transaction was not disclosed. The single state operator owns and operates two adult-use retail locations in Massachusetts. The acquisition also includes a third retail location, set to open in 2021 near Logan International Airport and the Encore Casino.

“Expanding our retail footprint throughout Massachusetts continues our Enter, Open, Scale strategy,” said Green Thumb Founder and Chief Executive Officer Ben Kovler. “With this acquisition, we have the maximum number of retail locations in the state, which directly supports the increased production capacity from our acquisition of Liberty Compassion in June. We are excited to work together with the GreenStar team to serve the massive demand for cannabis throughout the Commonwealth.”

In a statement, GTI noted that with the acquisition of GreenStar Herbals Inc., it now has two operational adult-use retail stores in Dracut and Maynard, with a third to open in Chelsea this year, and three medical-use retail stores in Amherst, Boston, and West Springfield. Green Thumb’s existing Rise Amherst store reverted to a medical cannabis store in August.

GreenStar Herbals Chief Executive Officer Thomas Morey added, “We are thrilled to partner with Green Thumb and to continue providing Massachusetts consumers with the highest quality and most diversified cannabis product offerings, along with a premiere in-store retail experience. Green Thumb’s expertise in the industry, along with the company’s values, vision, and emphasis on community impact made this the right partner for our team.”

It may have been slow to be established. but the Massachusetts recreational cannabis market has sold more than $1.5 billion in cannabis products since launching adult-use sales in 2018, according to the state’s Cannabis Control Commission, with daily sales averaging over $3 million so far in 2021. Adult-use cannabis sales in the state have reached nearly $755 million so far in 2021 and are projected to reach $1.2 billion by the end of the year.

Green Thumb’s branded products, including Rythm premium flower and vapes; Dogwalkers brand pre-roll joints; and Incredibles gummies, chocolates, and tarts, are produced in the Commonwealth and available at licensed cannabis dispensaries across Massachusetts. The company began serving medical patients in Massachusetts in 2018 and has two operational cultivation and production facilities in Holyoke and Clinton to serve the growing consumer demand for cannabis.

 


Debra BorchardtAugust 11, 2021
shutterstock_470312240.jpg?fit=960%2C641&ssl=1

5min6640

Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) reported its financial results for the second quarter ending June 30, 2021, with total revenue jumping by 85% to $221.9 million. Green Thumb’s revenue rose 14.1% sequentially and beat the average analyst estimate per Yahoo Finance of $205 million. Net income for the second quarter was $22.1 million or $0.10 per basic and diluted share, compared to a net loss of $12.9 million, or a loss of $0.06 per basic and diluted share in the prior year. This beat the average analyst estimate per Yahoo Finance which was $0.07.

GTI said that the revenue growth was primarily driven by increased scale in the Consumer Packaged Goods and Retail businesses, especially in Illinois and Pennsylvania. Overall performance was driven by the expanded distribution of Green Thumb’s branded products, 10 additional stores, and increased traffic in the Company’s 58 open and operating retail stores. In the second quarter of 2021, Green Thumb generated revenue from all 12 of its markets: California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New Jersey, New York, Ohio and Pennsylvania. The Company continued to invest in expanding its cultivation and manufacturing capabilities.

“The second quarter continued to be about disciplined execution and the team should be proud of the results. On a year-over-year basis, we grew revenue by 85% to $222 million; more than doubled Adjusted EBITDA to $79 million and continued to deliver positive cash flow. Since the first quarter, we closed three acquisitions, expanding our manufacturing capabilities in Massachusetts and geographic footprint into two new states, Virginia and Rhode Island. These critical steps strengthened our position to distribute our brands to more patients and consumers in existing and new markets,” said Green Thumb Chairman, Founder and Chief Executive Officer Ben Kovler.

In the second quarter 2021, EBITDA was $65.9 million or 29.7% of revenue versus $28.3 million or 23.6% of revenue in the prior year period. Adjusted Operating EBITDA, which excluded non-cash stock-based compensation of $5.7 million and other non-operating expenses of $7.7 million, was $79.3 million or 35.7% of revenue as compared to $35.4 million or 29.6% of revenue for the second quarter 2020. The improvement in EBITDA and Adjusted Operating EBITDA over the prior year period largely reflected revenue growth and increased scale-driven operating leverage from both the Consumer Packaged Goods and Retail businesses. For additional information on these non-GAAP financial measures, see below under “Non-GAAP Financial Information.”

“Finding new and meaningful ways to support the communities we serve is a mission we all share at Green Thumb. We are especially proud of our recently announced Good Green grant program for heroes helping to fight problems created by the failed War on Drugs. Ahead of launching the Good Green brand of products later this year, we are allocating at least $1,300,000 in social equity grants to qualified 501(c)(3) organizations over the next 18 months to jump start this important initiative,” said Kovler.

Expenses increased as total selling, general and administrative expenses for the second quarter were $72.1 million or 32.5% of revenue versus $49.6 million or 41.5% of revenue for the second quarter 2020. Improved operating costs as a percentage of revenue reflected increased operating leverage in the company’s Consumer Packaged Goods and Retail businesses.

“The great American growth story in cannabis is happening–the momentum is undeniable. Consumers demand safe, reliable alternatives for well-being and we are excited to meet their needs with high-quality cannabis experiences. There is still incredible untapped potential in all of our operating regions, and we will continue our strategy to invest in high-return initiatives that prepare us for the growth ahead and future value creation for our stakeholders,” concluded Kovler.


StaffMay 3, 2021
Virginia-2.jpg?fit=960%2C640&ssl=1

3min20190

Green Thumb Industries Inc. (GTI) (OTCQX: GTBIF) is buying Virginia-based  Dharma Pharmaceuticals LLC for an undisclosed amount. the acquisition is expected to close in the second half of 2021. Dharma was the first operator to provide medical products to Virginia’s patients in 2020 and is strategically positioned to scale in the emerging adult-use market. Last month, Virginia became the first Southeastern state in the United States to legalize adult-use cannabis after the Virginia General Assembly approved legislation.

“Change is happening. We are seeing sweeping cannabis reform across the country in favor of expanded access. This momentum has finally reached the first state south of the Mason-Dixon line to ratify adult-use cannabis sales and we are excited to work with the Dharma team in Virginia,” said Green Thumb Founder and Chief Executive Officer Ben Kovler. “This industry will create consequential economic opportunities and social change in a part of the country that remains void of legal access to cannabis today. We look forward to serving Virginia’s current medical patients, and future adult-use consumers, while supporting the tremendous positive impact that the legal cannabis industry can have on local communities.”

Currently, Virginia has only legalized medical marijuana and while adult use has been also legalized, sales won’t begin until January 2024. With a population of nearly 8.5 million, Virginia is expected to generate over $1.5 billion in legal cannabis sales, which would create significant tax revenue for the Commonwealth and employ thousands of Virginians.

GTI has been rapidly expanding throughout the U.S. Once this deal is closed, the company will have a presence in 13 markets: California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New Jersey, New York, Ohio, Pennsylvania, and Virginia. GTI noted that as one of only five licenses in the Virginia medical cannabis market, Dharma is licensed to grow, process, and retail cannabis directly to consumers. In a statement, the company said that the acquisition includes an existing production facility and retail dispensary located in Abingdon, VA. Green Thumb will also have the opportunity to open up to five additional retail locations in the Commonwealth.

Kevin Gibbs, Partner and Head of Operations of Merida Capital Holdings, which is the current majority-equity owner of Dharma, added, “Over the past two years our team has worked hard to introduce the first medical cannabis products to Virginia’s patients. Together with Green Thumb, Dharma’s offering will expand to prepare for the introduction of adult-use sales in the first market in the Southeastern United States.”

 


StaffApril 30, 2021
money-2.jpg?fit=960%2C640&ssl=1

5min10120

GTI

Green Thumb Industries Inc.  (OTCQX: GTBIF) announced that it has closed on a $217 million senior non-brokered private placement financing through the issuance of senior secured notes. GTI said it plans to use the proceeds to retire its existing $105 million senior secured debt due May 2023 and for general working capital purposes as well as various growth initiatives.

“History has taught us that the winners in new industries are those with the lowest cost of capital and the strongest balance sheets,” said GTI Founder and CEO Ben Kovler. “Our successful non-brokered offering (gross=net) was supported by members of the management team in addition to a diverse group of new and existing high-quality, institutional investors who share in our strategic vision and plan to capitalize on the opportunities ahead. This financing represents industry-leading cost of capital in the legal cannabis industry and strengthens our balance sheet. This new capital will allow us to focus on shareholder value creation through strategic investments to scale our existing operations in addition to accretive M&A opportunities.”

The Notes have a maturity date of April 30, 2024 and will bear interest from the date of issue at 7% per annum, payable quarterly, with an option, at the discretion of the company, to extend an additional 12 months. The financing permits the Company to borrow an additional $33 million over the next twelve months. The purchasers of the Notes also received an aggregate of 1,459,043 warrants. Each Warrant is exercisable to purchase one subordinate voting share of GTI at an exercise price of $32.68 per share, for a period of 60 months from the date of issue.

Cansortium

Cansortium Inc.  (OTCQB: CNTMF) has closed a $71 million Senior Secured Term Loan due April 29, 2025. The company plans on using the proceeds to repay convertible debentures that were due in May and strengthen the balance sheet. 

“Today marks a new beginning for Cansortium as we now have the financial flexibility and liquidity that the Company needs to continue growing its attractive asset base,” said Chief Executive Officer Robert Beasley. “Proceeds from the Term Loan have been used to satisfy substantially all of the Company’s existing indebtedness, including repaying $27.1 million of convertible debentures due in May. These actions have resulted in more than $40 million of cash being added to our balance sheet from the Term Loan and the equity offering completed earlier this month. With a strengthened balance sheet and simplified capital structure, we are now firmly positioned to execute our growth and expansion initiatives in our core FloridaPennsylvania, and Michigan markets.”

Neal Hochberg, Cansortium’s Chairman of the Board added, “By extending our debt maturities by four years and bolstering our liquidity, the Company can now focus all of its attention on maximizing value.”

Mr. Beasley added, “Since taking over as CEO in September 2020 , we have made dramatic improvements across key aspects of our business, particularly in Florida where we have significantly increased cultivation yields, introduced new SKUs and form-factors such as edibles, and expanded cultivation and production capacity to better supply our 24 operational dispensaries (expected to increase to 27 by year-end). Florida remains the single largest limited-license cannabis market in the U.S. and we currently have the sixth largest footprint in the state. I am proud of our team’s early accomplishments up to this point and look forward to capitalizing on the many growth opportunities ahead.”

 


Debra BorchardtMarch 31, 2021
Rise.jpg?fit=880%2C586&ssl=1

4min16060

Earlier this week, the Chicago Tribune ran a story alleging that cannabis company Green Thumb Industries Inc. (OTCQX: GTBIF) was under federal investigation for possible pay-to-play violations during its push for coveted state licenses. The article cited an unnamed source. The story claimed that investigators were looking into campaign donations as the company was seeking licenses in Illinois. No charges have been filed in the investigation according to the story. The stock fell over 11% in trading on Tuesday as the article made the rounds.

The story was relatively vague and stated, “It’s unclear what specific aspects of Green Thumb’s political giving, hiring or other activities are being scrutinized by federal authorities. The exact time frame and origin of the probe were not known.”

In a statement, Green Thumb said it possesses absolutely no evidence to corroborate claims that there is an open investigation by federal authorities as alleged in an article by the Chicago Tribune under a misleading headline published on March 29, 2021.

Green Thumb said it first learned of the alleged probe into supposed violations regarding obtaining licenses from a Chicago Tribune reporter who cited unnamed sources shortly before the article was published. The company went on to say that Federal authorities have made no effort to initiate contact with Green Thumb.

“The Chicago Tribune has published unfounded allegations that completely contradict our corporate values,” said Green Thumb Founder and CEO Ben Kovler. “The reporter did not cite any credible sources nor evidence, and published under a salacious front page headline intended to mislead. This is not just irresponsible journalism but reckless behavior that impacts the livelihood of our employees, the close bond to the communities in which we serve, and the trust of our investors. Our company has secured licenses through competitive state-run programs and traditional M&A transactions. We have taken painstaking measures to scale compliantly as we provide access to well-being through cannabis, and will continue to hold ourselves to the highest standards.”

The article did state that records showed that GTI’s executives and affiliates donated to a number of politicians as well as a political action committee that was instrumental in the marijuana legalization effort. However, that is common practice in every state where companies are pushing for legalization. The story didn’t mention whether other Illinois license holders had also donated to the legalization effort.

The story said that the company also hired lobbyists and consultants with deep ties to then-House Speaker Michael Madigan. Yet, it failed to note that most of the license holders in the state also helped support the fight for legalization by making donations.


Debra BorchardtFebruary 9, 2021
money.jpg?fit=960%2C640&ssl=1

4min20260

Green Thumb Industries Inc. (OTCQX: GTBIF) filed a Form S-1 registration statement to sell up to 10 million of its subordinate voting shares. Shortly following becoming effective, Green Thumb said it received and accepted an offer from a single institutional investor to purchase approximately 3.1 million registered subordinate voting shares at $32.03 per share for a total of $100 million.  The sale will close on February 9, 2021.  The company said that the principal purpose of this offering is to increase Green Thumb’s capitalization and financial flexibility.

“Institutional investors are waking up to the great American cannabis growth story,” said Green Thumb Founder and Chief Executive Officer Ben Kovler.“This investment reflects the very real interest, understanding, and momentum behind the potential $100 billion U.S. cannabis opportunity that is happening now. The industry needs more meaningful access to capital to unleash the true economic and social growth potential. The next step should be allowing U.S. cannabis companies to formally list on major U.S. exchanges just like our Canadian counterparts. The U.S. cannabis industry creates jobs, tax revenue, and has the opportunity to address head on some of the major injustices and inequities brought on by the War on Drugs.”

The company did not disclose the name of the buyer. GTI stock was lately selling at roughly $33, near the company’s 52-week high of $34 and far exceeding the year’s low of $3.69.

Strong Earnings

GTI is a leading cannabis consumer packaged goods company and the owner of Rise Dispensaries. In November, the company reported its earnings for the third quarter of 2020. Overall, the company’s balance sheet was strong and retained a positive cash flow for the third consecutive quarter. Green Thumb’s revenue increased 31.3% quarter-over-quarter, and year-over-year 131.% to $157.1 million. The company’s gross margin for the third quarter of 2020 was 55.4%, an increase from a 53.2% gross margin the quarter prior.

The company’s adjusted operating EBITDA increased by 50% to $53.2 million, or 33.9% of revenue for the third quarter of 2020. The prior quarter ended with an adjusted EBITDA of $35.4 million, or 29.6% of revenue. As of September 30th, 2020, Green Thumb’s current assets totaled $159.1 million and included cash and cash equivalents equaling $78.1 million. The company reported a total debt outstanding of $97.1 million, $0.3 million being due within 12 months.

Retail revenue increased by 27.9% quarter-over-quarter, primarily being driven by increased foot traffic in established stores. Comparable sales growth exceeded 65%, on a base of 25 stores. Green Thumb Industries also partnered with the Last Prisoner Project in an attempt to help raise awareness and funds towards the incredibly important cause. The company also announced the launch of the License Education Assistance Program, designed to equip social equity business applicants for success in Illinois.

Headquartered in Chicago, Illinois, Green Thumb has 13 manufacturing facilities, licenses for 97 retail locations and operations across 12 U.S. markets. Established in 2014, Green Thumb employs over 2,300 people and serves thousands of patients and customers each year.

 


Julie AitchesonJune 1, 2020
sunnyside.jpg?fit=480%2C270&ssl=1

7min14550

With terms like “social distancing”, “quarantine”, and “safer at home” orders now common parlance thanks to the Covid-19 global pandemic, it seems an odd time to forge ahead with opening new retail establishments, yet several determined cannabis companies are betting on a better future and doing just that.

 Small business website “The Balance” itemizes the expenses associated with opening a storefront, which include licensing fees, rent, inventory, staffing, and equipment to name a few.  To open even a small business in an inexpensive city or town can cost thousands of dollars. Factor in the extra costs retailers will have to swallow to stay within Covid-19 guidelines for reopening such as plexiglass cashier guards, protective equipment for staff, and restrictions on the number of customers allowed in the store at any one time, and the overhead becomes untenable for many current and aspiring shop owners.

New Dispensaries

Despite these factors, companies like cannabis product manufacturer Green Thumb Industries, cannabis testing laboratory Cannasafe, and cannabis retailer Canna Provisions are expanding their enterprises.

Green Thumb Industries (OTC:GTBIF)  announced that it would be opening its fourth retail location in the Las Vegas, NV area on May 13, as well as the eighth store in Illinois on May 28. This makes for a total of forty-five storefronts nationwide for Green Thumb, with four new locations opening since the Covid-19 crisis began. 

Green Thumb’s approach involves an emphasis on efficient curbside pick-up and delivery strategies to safeguard customer and staff safety. In a May 26 press release about the new Illinois location, Green Thumb Industries founder and chief executive Ben Kovler stated that his company has “continued to move forward through the ongoing COVID-19 crisis to provide jobs and much-needed access to well-being through the power of cannabis during these difficult times, as demonstrated by the opening of Rise Niles, our fourth opening since the crisis began.”

Cresco Labs  (OTCQX:CRLBF) opened Sunnyside River North, the first Illinois adult-use dispensary in Chicago in the prestigious River North neighborhood. Sunnyside opened for adult-use cannabis sales on May 28th for online orders and in-store pick up that day through a pop-up retail experience. “We are thrilled to be opening the first adult use store in Chicago under the state’s new legislation and to provide an example of what normalized and professionalized cannabis looks like with a location in a traditional business district, a local and diverse operating team and a tremendous amount of community input and support,” said Charlie Bachtell, Cresco Labs’ CEO and Co-founder.

Cresco Labs has said it has implemented procedures system-wide to eliminate wait lines, crowding, and social distancing during the COVID-19 pandemic and the River North location will launch with online orders only through Sunnyside.shop. Once customers receive a text notification that their order is ready, they can check-in at the Guest Experience Center at 22 W. Hubbard to be entered into the virtual pickup queue.

Meanwhile, Cannasafe has announced the opening of three new ISO-accredited laboratories in Oregon, Florida, and Illinois to help meet the increased demand for cannabis during the pandemic. Canna Provisions has opened a new storefront in Easthampton, MA with another in nearby Holyoke slated to open shortly. Another Lee, MA location shut down due to the pandemic will also be reopening. Canna Provisions is using a quick transaction model involving ID checks, a wireless ATM card reader, and frequent sanitizing to facilitate safe customer interface while offering additional support via Zoom links and instructional videos to help customers understand the new system. 

These considered moves by some of the industry’s best-known names have all of the makings of successful ventures, especially given the attention to the potential infection hazards inherent in storefront retail. Still, as demand for cannabis continues strong and companies build capacity to meet that demand, it remains to be seen whether Covid-19 and a potential “second wave” will frame a gamble on the future of in-person sales as one worth taking or not.


StaffMay 7, 2020
gti.jpg?fit=850%2C531&ssl=1

4min25370

Executive Spotlight: Wendy Alison Berger

Title: Board Director / Member of the Board

Company: Green Thumb Industries OTC:GTBIF / CannaVu

Years at current company: 5 years / recent

Education profile:

Syracuse University: Bachelor of Science, Finance and Marketing, 1988

Northwestern University Kellogg School of Management; MBA, Finance and Real Estate, 1993

Most successful professional accomplishment before cannabis: Following my entrepreneurial dream and creating WBS Equities, LLC which specializes in ground-up construction, renovation, development, sale-leaseback transactions and acquisitions of food manufacturing and food distribution facilities.  I’m also incredibly proud of having co-founded Illinois Women in Cannabis in 2014 with GTI’s Senior Vice President of Government and Regulatory Affairs Dina Rollman. IWC connects, educates, mentors, and supports Illinois women of all ages and backgrounds in order to maximize their opportunities in the emerging Illinois cannabis industry.

Company Mission: GTI’s mission is to promote well-being through the power of cannabis. CannaVu’s is to provide advertisers the ability to purchase digital advertising while meeting and exceeding state and federal requirements.

Company’s most successful achievement:  It’s hard to choose one “most successful” achievement for Green Thumb but I think what stands out most is how we’ve created the right team to thrive in a highly dynamic and evolving industry, and our diligent approach to capital allocation. CannaVu is the best at what it does and I’m excited about the achievements we’ll make this year.

Has the company raised any capital (yes or no): Yes

If so, how much?: GTI has raised $250 million in equity since 2018 and $105 million in debt.

Any plans on raising capital in the future? We like the position of our balance sheet. With our recent sale and leaseback transactions and the cash flow generated from our business operations, our growth plans are funded, and we are optimistic about our future. CannaVu may raise capital this year.

Most important company 5-year goal: GTI wants to continue to expand access to Green Thumb’s branded cannabis products such as Beboe, Dogwalkers, Dr. Solomon’s, Incredibles, Rythm, and The Feel Collection that help the well-being of so many people. CannaVu wants to remain the premier platform for canna-compliant digital advertising.


Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 9 hours

Has your Monday been a MONDAY? Us too. Take a hit. A

@GreenMarketRpt – 10 hours

Grab your popcorn, this should be entertaining $MMNFF

@GreenMarketRpt – 10 hours

If you missed last week’s check out this video. Cute dogs and no fights

Back to Top

Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.